A new paper, published last week in Applied Economics, by Dimitrios Kourouklis, Senior Economist at OHE, looks at the question of whether government funding increases public sector development of new medicines. Looking at public sector drug development in Europe, this paper suggests that government funding does have an impact on the research and development pipeline, particularly at the earlier stages of research for medicines targeting rare diseases.
‘Cascades of care’ have emerged as an attractive tool for assessing access to care for numerous chronic diseases. Dr Haacker will examine the use of cascades of care across diseases and populations, evaluate the use of cross-sectional targets in disease control strategies (e.g., the UNAIDS 90-90-90 targets), and address implications for cost-effectiveness analysis.
Research just published in Public Administration Review, co-authored by OHE’s Professor Graham Cookson, demonstrates that contracting out auxiliary public services may lower the quality of the core service as well as the auxiliary service. Studying NHS cleaning services, the research shows that contracted out cleaning is cheaper but lower quality and leads to worse health outcomes including higher rates of hospital-acquired infections.
OHE Lunchtime Seminar with NHS Improvement Economics Team Members Sarah Karlsberg, Steven Paling and Júlia Esquerré. The seminar will present evidence on where NHS trusts can take practical steps to reduce cancer waiting times. The project won the 2018 John Hoy Memorial Award for the best piece of economic analysis produced by government economists.
The latest publication from Professor Graham Cookson in Public Organization Review finds that waiting time targets adopted in the English NHS as part of the ‘targets and terror’ performance management regime did indeed reduce key waiting time measures, but at the expense of other quality metrics such as hospital readmission rates i.e. the policy was output distorting.